Nutrition Support of Patients With Enterocutaneous Fistulas

Nutrition in Clinical Practice

Volumn 13, Issue 2, 1998, Pages 59-65

  Fukuchi, Steven ^a   Seeburger, Jeffrey ^a   Parquet, Guido ^a   Rolandelli, Rolando ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84992875374     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/088453369801300202     Document Type: Article

References (57)

1. Berry SM, Fischer JE. Classification and pathophysiology of enterocutaneous fistulas. Surg Clin North Am 1996; 76: 1009–18.
2. Rombeau JL, Rolandelli RH. Enteral and parenteral nutrition in patients with enteric fistulas and short bowel syndrome. Surg Clin North Am 1987; 67: 551–71.
3. Edmunds LH, Williams GM, Welch CE. External fistulas arising from the gastrointestinal tract. Ann Surg 1960; 152: 445–71.
4. Berry SM, Fischer JE. Enterocutaneous fistulas. Curr Prob Surg 1994; 31: 471–564.
5. Rolandelli RH, Roslyn JJ. Surgical management and treatment of sepsis associated with gastrointestinal fistulas. Surg Clin North Am 1996; 67: 1111–22.
6. Smith DW, Lee RM. Nutritional management in duodenal fistulas. Surg Gynecol Obstet 1956; 103: 666–72.
7. Bury KD, Stephens RV, Randall HT. Use of a chemically defined, liquid, elemental diet for nutritional management of the alimentary tract. Am J Surg 1971; 121: 174–83.
8. Voitk AJ, Echave V, Brown RA, et al. Elemental diets in the treatment of fistulas of the alimentary tract. Surg Gynecol Obstet 1973; 137: 68–72.
9. Rocchio MA, Cha CM, Haas KF, et al. Use of chemically defined diets in the management of patients with high output gastrointestinal fistulas. Am J Surg 1974; 127: 148–53.
10. Reber HA, Roberts C, Way L, et al. Management of external gastrointestinal fistulas. Ann Surg 1978; 188: 460–7.
11. Soeters PB, Ebeid AM, Fischer JE. Review of 404 patients with gastrointestinal fistulas. Ann Surg 1979; 190: 189–202.
12. MacFayden BV, Dudrick SJ, Ruberg RL. Management of gastrointestinal fistulas with parenteral hyperalimentation. Surgery 1973; 74: 100–5.
13. Ryan JA Jr, Adye BA, Weinstein AJ. Enteric fistulas. In: Rombeau JL, Caldwell MD, eds. Clinical nutrition, vol II, Parenteral nutrition. Philadelphia: WB Saunders, 1986; 419–36.
14. Himal HS, Allard JR, Nadea JE, et al. The importance of adequate nutrition in closure of small intestinal fistulas. Br J Surg 1974; 61: 724–30.
15. Deitel M. Nutritional management of external gastrointestinal fistulas. Can J Surg 1976; 19: 505–9.
16. Tilson MD. Pathophysiology and treatment of short bowel syndrome. Surg Clin North Am 1980; 60: 1273–84.
17. Graham JA. Conservative treatment of gastrointestinal fistulas. Surg Gynecol Obstet 1977; 144: 512–14.
18. Kaminsky MV, Deitel M. Nutritional support in the management of external fistulas of the alimentary tract. Br J Surg 1975; 62: 100–3.
19. Silberman H, Granson M, Fong G, et al. Management of gastrointestinal fistulas with glucose and lipids. Surg Gynecol Obstet 1980; 150: 856–8.
20. Aguirre A, Fischer JE, Welch CE. The role of surgery and hyperalimentation in therapy of gastrointestinal-cutaneous fistulae. Ann Surg 1974; 180: 393–401.
21. Kuvshinoff BW, Brodish RJ, McFadden DW, et al. Serum transferrin as a prognostic indicator of spontaneous closure and mortality in gastrointestinal cutaneous fistulas. Ann Surg 1993; 217: 615–23.
22. Rose D, Yarborough MF, Canizaro PC, et al. One hundred and fourteen fistulas of the gastrointestinal tract treated with total parenteral nutrition. Surg Gynecol Obstet 1986; 163: 345–50.
23. Taranzi R, Coutsoftides T, Steiger E, et al. Gastric and duodenal cutaneous fistulas. World J Surg 1983; 7: 463.
24. Foster CE III, Lefor AT. General management of gastrointestinal fistulas. Surg Clin North Am 1996; 76: 1019–33.
25. Jaques P, Mauro M, Safrit H, et al. CT features of intraabdominal abscesses: prediction of successful percutaneous drainage. Am J Roentgenol 1986; 146: 1041–5.
26. Lambiase RE, Deyoe L, Cronan JJ, et al. Percutaneous drainage of 335 consecutive abscess: results of primary drainage with 1-year follow-up. Radiology 1992; 184: 167–79.
27. Schecter S, Eisenstat TE, Oliver GC, et al. Computerized tomographic scan-guided drainage of intra-abdominal abscesses. Dis Colon Rectum 1994; 37: 984–8.
28. Fischer JE. The pathophysiology of enterocutaneous fistulas. World J Surg 1983; 7: 446–50.
29. McLean GK. Radiologic techniques of gastrointestinal intubation. In: Rombeau JL, Caldwell MD, eds. Clinical nutrition, Vol I. Enteral nutrition. Philadelphia: WB Saunders, 1984; 240–52.
30. Levy E, Palmer DL, Frileux P, et al. Inhibition of upper gastrointestinal secretions by reinfusion of succus entericus into the distal small bowel. A clinical study of 30 patients with peritonitis and temporary enterostomy. Ann Surg 1983; 198: 596–600.
31. Levy E, Frileux P, Cugnenc PH, et al. High-output external fistulae of the small bowel: management with continuous enteral nutrition. Br J Surg 1989; 76: 676–9.
32. DeBiasse MA, Wilmore DW. What is optimal nutritional support? New Horizons 1994; 2: 122–30.
33. Koruda MJ. Dietary fiber and gastrointestinal disease. Surg Gynecol Obstet 1993; 177: 209–14.
34. LeLeiko NS, Walsh MJ. The role of glutamine, short-chain fatty acids, and nucleotides in intestinal adaptation to gastrointestinal disease. Ped Clin North Am 1996; 43: 451–70.
35. Fisher JE. Enterocutaneous fistula. In: Cameron JE, ed. Current surgical therapy, 4th ed. St Louis: Mosby-Year Book, 1992; 136–42.
36. Grauer L, Barkin JS. Role of somatostatin and octreotide in the treatment of pancreatic pseudocyst, fistula and ascites. Dig 1994: 55 (Suppl 1):24–8.
37. Pederzoli P, Bassi C, Falconi M, et al. Conservative treatment of external pancreatic fistulas with parenteral nutrition alone or in combination with continuous intravenous infusion on somatostatin, glucagon or calcitonin. Surg Gynecol Obstet 1986; 163: 428–32.
38. Bauer W, Briner U, Doepfner W, et al. SMS 201–995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 1982; 31: 1133–40.
39. Chanson P, Timsit J, Harris AG. Clinical pharmacokinetics of octreotide: therapeutic applications in patients with pituitary tumors. Clin Pharmacokinet 1993; 25: 375–91.
40. Fuessl HS, Caolan G, Williams G, et al. Effect of a long-acting somatostatin analogue (SMS 201–995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Digestion 1987; 36: 101–7.
41. Lembcke B, Creutzfeld W, Schleser S, et al. Effects of the somatostatin analogue Sandostatin (SMS 201–995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion 1987; 36: 108–24.
42. Nubiola-Calonge P, Badia JM, Sancho J, et al. Blind evaluation of the effect of octreotide (SMS 201–995), a somatostatin analogue, on small-bowel fistula output. Lancet 1987; 2: 672–4.
43. Nubiola P, Badia JM, Martinez-Rodenas F, et al. Treatment of 27 postoperative enterocutaneous fistulas with the long half-life somatostatin analogue SMS 201–995. Ann Surg 1989; 210: 56–8.
44. Sitges-Serra A, Jaurrita E, Sitges-Creus A. Management of postoperative enterocutaneous fistulas: the roles of parenteral nutrition and surgery. Br J Surg 1982; 69: 147–50.
45. Zinner MJ, Baker RR, Cameron JL. Pancreatic cutaneous fistulas. Surg Gynecol Obstet 1974; 138: 710–2.
46. Martineau P, Shwed J, Denis R. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure? Am J Surg 1996; 172: 386–96.
47. Torres AJ, Landa JI, Moreno-Azcoita M, et al. Somatostatin in the management of gastrointestinal fistulas. Arch Surg 1992; 127: 97–100.
48. Spiliotis J, Briand D, Gouttebel MC, et al. Treatment of fistulas of the gastrointestinal tract with total parenteral nutrition and octreotide in patients with carcinoma. Surg Gynecol Obstet 1993; 176: 575–80.
49. Boike GM, Sightler SE, Averette HE. Treatment of small intestinal fistulas with octreotide, a somatostatin analog. J Surg Oncol 1992; 49: 63–5.
50. Borison DI, Bloom AD, Pritchard TJ. Treatment of enterocutaneous and colcutaneous fistulas with early surgery or somatostatin analog. Dis Colon Rectum 1992; 35: 635–9.
51. Chen RJ, Fang JF, Chen MF. Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding. Am J Gastroenterol 1992; 87: 1212–5.
52. Katz MD, Erstad BL. Octreotide, a new somatostatin analogue. Clin Pharm 1989; 8: 255–73.
53. Sancho JJ, DiCostanzo J, Nubiola P, et al. Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995; 82: L638–641.
54. Popovic V, Chayvialle JA, Wass JAH. Proceedings of the discussion: tolerability and safety of Sandostatin. Digestion 1993; 54 (Suppl 1):104–6.
55. Dowling RH, Hussaini SH, Murphy GM, et al. Gallstones during octreotide therapy. Digestion 1993; 54 (Suppl 1):107–20.
56. Katz MD, Erstad BL. Octreotide, a new somatostatin analogue. Clin Pharm 1989; 8: 255–73.
57. Kraenzlin ME, Wood SM, Neufeld M, et al. Effect of long-acting somatostatin-analogue, SMS 201–995 on gut hormone secretion in normal subjects. Experientia 1985; 41: 738–40.